Search results
Found 1078 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Oxford University welcomes UK regulatory emergency use authorisation of coronavirus vaccine
Clinical Trials Coronavirus COVID-19 General Research
30 December 2020
The University of Oxford welcomes the news that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK.
Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research
Coronavirus COVID-19 General Research
18 December 2020
In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.
Oxford vaccine stimulates broad antibody and T cell functions
Clinical Trials Coronavirus COVID-19 Research
17 December 2020
Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing the decision to move to a two-dose regimen in ongoing phase III trials, and how ChAdOx1 nCov-19 induces broad antibody and T cell functions.
Launch of new Scan Academy webinars
General Research
16 December 2020
Nuffield Department of Women's and Reproductive Health celebrate the successful launch of scan.academy - an initiative dedicated to improving obstetric ultrasound through state-of-the-art education.
Plastic surgeons recommend a review of cancer excision guidelines after finding variations in effectiveness
General Research
15 December 2020
A systematic review finds incomplete excision rates for basal cell carcinoma range from 4.7% to 20.4%, against recommended guidelines of 5%.
Cochrane ENT awarded NIHR funding for COVID-19 project
Coronavirus COVID-19 General Research
11 December 2020
Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.
National COVID-19 Infections Survey reveals changes to pandemic over time
Coronavirus COVID-19 General Research
11 December 2020
Data from the National COVID-19 Infection Survey, done in partnership between the University of Oxford, the Office of National Statistics, Public Health England, University of Manchester and the Wellcome Trust, has revealed detailed characteristics of England’s coronavirus pandemic, including which factors have contributed most to case numbers over different phases and the prevalence of asymptomatic infections.
Key step for hepatitis research as patient database created
General Research
11 December 2020
For the first time, a comprehensive database comprising an initial cohort of more than 1,300 patients with chronic hepatitis B or hepatitis C infections has been developed for potential future research into the conditions.
University of Oxford awarded major European Research Council funding
Awards and Appointments General Research
9 December 2020
European Research Council grants worth more than €16.3 million have today been awarded to eight University of Oxford researchers for a range of cutting-edge projects.
First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
Clinical Trials Coronavirus COVID-19 General Research
8 December 2020
Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
Hidden damage to lungs from COVID-19 revealed in new research study from University of Oxford & Sheffield
Coronavirus COVID-19 General Research
2 December 2020
Early findings from a study into longer-term damage amongst patients recovering from COVID-19 suggest that the use of cutting-edge scanning techniques may detect previously unseen lung damage.
SCALOP team discover new pancreatic cancer biomarker
General Research
30 November 2020
The discovery of pancreatic cancer biomarkers (naturally occurring molecules, genes or characteristics which can be used to confirm the presence or predict the outcome of a cancer) is vital in understanding patient outcomes and finding new therapeutic targets.
A clue to how a memory-enhancing pill might work
General Research
27 November 2020
Hundreds of dietary supplements have been reported to improve cognitive and emotional function in humans, but few have scientific foundation. A new study from the Department of Physiology, Anatomy & Genetics (DPAG) provides fresh insight into how dietary magnesium supplementation can influence memory performance.
Inhaled corticosteroids to be investigated as a possible treatment for Covid-19 in national PRINCIPLE Trial
Coronavirus COVID-19 General Research
27 November 2020
In Covid-19, inhaled budesonide may prevent damaging inflammation, stop the virus from getting into lung cells and inhibit viral replication.
New MRI technique could detect early signs of heart failure in cancer patients following chemotherapy
General Research
25 November 2020
New research led by Department of Physiology, Anatomy & Genetics researcher Dr Kerstin Timm shows that a recently developed imaging technique can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.
Oxford vaccine team shortlisted for parliamentary awards
Awards and Appointments Coronavirus COVID-19 Research
24 November 2020
The University of Oxford team who have developed a COVID-19 vaccine in record time have been shortlisted for the Excellence in Healthcare Award at the NHS Parliamentary Awards.
Oxford University breakthrough on global COVID-19 vaccine
Coronavirus COVID-19 General Research
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
People in prison should be prioritised for any COVID-19 vaccine
Coronavirus COVID-19 General Research
20 November 2020
Preventing serious complications from COVID-19 in potentially vulnerable populations in high risk environments, such as prisons, and preventing spread to surrounding communities needs a coordinated evidence-based approach to managing outbreaks of COVID-19 in prison settings.
Prior COVID-19 infection offers protection from re-infection for at least six months
Coronavirus COVID-19 General Research
20 November 2020
A new study suggests that individuals who have previously had COVID-19 are highly unlikely to contract the illness again, for at least six months following their first infection.